JP2002509074A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002509074A5 JP2002509074A5 JP2000528300A JP2000528300A JP2002509074A5 JP 2002509074 A5 JP2002509074 A5 JP 2002509074A5 JP 2000528300 A JP2000528300 A JP 2000528300A JP 2000528300 A JP2000528300 A JP 2000528300A JP 2002509074 A5 JP2002509074 A5 JP 2002509074A5
- Authority
- JP
- Japan
- Prior art keywords
- heat shock
- shock protein
- use according
- hsp
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 13
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 13
- 239000003814 drug Substances 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 241000124008 Mammalia Species 0.000 description 3
- 101710098119 Chaperonin GroEL 2 Proteins 0.000 description 2
- 206010014950 Eosinophilia Diseases 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000028709 inflammatory response Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 230000004043 responsiveness Effects 0.000 description 2
- 102100038222 60 kDa heat shock protein, mitochondrial Human genes 0.000 description 1
- 101710154868 60 kDa heat shock protein, mitochondrial Proteins 0.000 description 1
- 102100032510 Heat shock protein HSP 90-beta Human genes 0.000 description 1
- 102100039165 Heat shock protein beta-1 Human genes 0.000 description 1
- 101710100504 Heat shock protein beta-1 Proteins 0.000 description 1
- 101001016856 Homo sapiens Heat shock protein HSP 90-beta Proteins 0.000 description 1
- 101000839464 Leishmania braziliensis Heat shock 70 kDa protein Proteins 0.000 description 1
- 101000988090 Leishmania donovani Heat shock protein 83 Proteins 0.000 description 1
- 208000002200 Respiratory Hypersensitivity Diseases 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 230000010085 airway hyperresponsiveness Effects 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1233098A | 1998-01-23 | 1998-01-23 | |
| US09/012,330 | 1998-01-23 | ||
| PCT/US1999/001421 WO1999037319A1 (en) | 1998-01-23 | 1999-01-22 | Method for treating inflammatory diseases using heat shock proteins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002509074A JP2002509074A (ja) | 2002-03-26 |
| JP2002509074A5 true JP2002509074A5 (enExample) | 2006-03-09 |
Family
ID=21754459
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000528300A Pending JP2002509074A (ja) | 1998-01-23 | 1999-01-22 | 熱ショックタンパク質を使用する、炎症性疾患を処置する方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20020006410A1 (enExample) |
| EP (1) | EP1049483A1 (enExample) |
| JP (1) | JP2002509074A (enExample) |
| KR (1) | KR20010040389A (enExample) |
| CN (1) | CN1324243A (enExample) |
| AU (1) | AU2337499A (enExample) |
| BR (1) | BR9907228A (enExample) |
| CA (1) | CA2318263A1 (enExample) |
| CZ (1) | CZ20002669A3 (enExample) |
| HU (1) | HUP0100241A2 (enExample) |
| IL (1) | IL137404A0 (enExample) |
| NO (1) | NO20003775L (enExample) |
| PL (1) | PL342166A1 (enExample) |
| TR (1) | TR200002973T2 (enExample) |
| WO (1) | WO1999037319A1 (enExample) |
| ZA (1) | ZA99499B (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7992572B2 (en) * | 1998-06-10 | 2011-08-09 | Asthmatx, Inc. | Methods of evaluating individuals having reversible obstructive pulmonary disease |
| US6638518B1 (en) * | 1999-02-22 | 2003-10-28 | University Of Iowa Research Foundation | Method for inhibiting inflammatory responses |
| US6737398B1 (en) | 1999-09-30 | 2004-05-18 | National Jewish Medical And Research Center | Modulation of γδ T cells to regulate airway hyperresponsiveness |
| EP1229790A4 (en) * | 1999-09-30 | 2004-06-16 | Nat Jewish Med & Res Center | MODULATION OF -G (G) -G (D) T CELLS FOR REGULATING THE RESPIRATORY HYPERSENSITIVITY |
| US7235649B2 (en) * | 2000-03-24 | 2007-06-26 | Duke University | Isolated GRP94 ligand binding domain polypeptide and nucleic acid encoding same, and screening methods employing same |
| GB0028122D0 (en) * | 2000-11-17 | 2001-01-03 | St Georges Entpr Ltd | Method |
| AUPR381601A0 (en) * | 2001-03-19 | 2001-04-12 | Monash University | Method of treating respiratory conditions |
| WO2003029419A2 (en) * | 2001-10-01 | 2003-04-10 | Duke University | Three dimensional structure of crystalline grp94 binding domain, and its methods of use |
| US20030216315A1 (en) * | 2002-02-13 | 2003-11-20 | Duke University | Modulation of immune response by non-peptide binding stress response polypeptides |
| KR100615389B1 (ko) * | 2002-08-23 | 2006-08-25 | (주)헬릭서 | 다래 추출물을 함유하는 알러지성 질환 및 비알러지성염증 질환의 예방 및 개선용 건강 기능 식품 |
| US20100111927A1 (en) * | 2002-08-23 | 2010-05-06 | Sunyoung Kim | Compositions Comprising Actinidia and Methods of Use Thereof |
| GB0226105D0 (en) * | 2002-11-08 | 2002-12-18 | St Georges S Entpr Ltd | Pain relief agents |
| KR20080075505A (ko) * | 2005-10-20 | 2008-08-18 | 씨바이오 리미티드 | 과민증의 치료 방법 |
| KR100768265B1 (ko) * | 2005-11-10 | 2007-10-17 | 한국화학연구원 | 혈액내 순환시간을 향상시키기 위한 헤파린이 수식된리포솜 및 이의 제조방법 |
| ES2963910T3 (es) | 2008-06-26 | 2024-04-03 | Zevra Denmark As | Uso de Hsp70 como regulador de la actividad enzimática |
| WO2010086418A1 (en) * | 2009-01-29 | 2010-08-05 | Alfa Biogene International B.V. | Functional food product comprising heat shock protein or a hydrolysate thereof |
| EP2397074B1 (en) | 2010-06-19 | 2012-10-24 | M Stenqvist AB | A system and computer readable medium for determination of transpulmonary pressure in a patient connected to a breathing apparatus |
| PT2646044T (pt) | 2010-11-30 | 2019-11-12 | Orphazyme As | Métodos para aumentar a atividade intracelular de hsp70 |
| WO2012097255A2 (en) * | 2011-01-14 | 2012-07-19 | Scott & White Healthcare | Therapeutic effect of heat shock proteins in preventing amylin aggregation in type 2 diabetes mellitus |
| PT2707101T (pt) | 2011-05-12 | 2019-05-30 | Proteostasis Therapeutics Inc | Reguladores da proteostase |
| US20140228315A1 (en) * | 2011-06-16 | 2014-08-14 | Children's Hospital Medical Center | Blockade of eosinophil production by toll-like receptors |
| US10034915B2 (en) | 2011-06-23 | 2018-07-31 | The Board Of Trustees Of The Leland Stanford Junior University | Small heat shock proteins and active fragments thereof as a therapy for inflammation and ischemia |
| CA2861464C (en) | 2012-01-25 | 2018-03-06 | Proteostasis Therapeutics, Inc. | Proteasome activity modulating tricyclic compounds |
| HUE054957T2 (hu) | 2014-09-15 | 2021-10-28 | Orphazyme As | Arimoklomol készítése |
| EP3402572B1 (en) | 2016-01-13 | 2022-03-16 | Children's Hospital Medical Center | Compositions and methods for treating allergic inflammatory conditions |
| US10898476B2 (en) | 2016-04-13 | 2021-01-26 | Orphazyme A/S | Heat shock proteins and cholesterol homeostasis |
| RU2021117465A (ru) | 2016-04-29 | 2021-07-22 | Орфазим А/С | Аримокломол для лечения ассоциированных с глюкоцереброзидазой нарушений |
| CN106220718B (zh) * | 2016-08-04 | 2019-12-10 | 上海市农业科学院 | 一种草菇热激蛋白VvHSP60及其应用 |
| CN106243203B (zh) * | 2016-08-04 | 2019-12-10 | 上海市农业科学院 | 一种草菇热激蛋白VvHSP70及其应用 |
| US11859250B1 (en) | 2018-02-23 | 2024-01-02 | Children's Hospital Medical Center | Methods for treating eosinophilic esophagitis |
| EP3781588B1 (en) | 2018-04-20 | 2024-10-30 | Children's Hospital Medical Center | Blood biomarker for eosinophilic gastrointestinal disorders |
| WO2020006269A1 (en) | 2018-06-27 | 2020-01-02 | Proteostasis Therapeutics, Inc. | Proteasome activity enhancing compounds |
| BR112020026580A2 (pt) | 2018-06-27 | 2021-03-23 | Proteostasis Therapeutics, Inc. (Fem) | Compostos, composição farmacêutica e métodos para tratar um paciente |
| US12297501B2 (en) | 2019-02-25 | 2025-05-13 | Children's Hospital Medical Center | Methods for diagnosing and treating eosinophilic gastritis |
| IL303026A (en) | 2020-11-19 | 2023-07-01 | Zevra Denmark As | Processes for preparing arimoclomol citrate and intermediates thereof |
| CN114046596B (zh) * | 2021-11-17 | 2022-09-23 | 重庆大学 | 基于trp生化指标检测的室内空气质量控制系统及方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5348945A (en) * | 1990-04-06 | 1994-09-20 | Wake Forest University | Method of treatment with hsp70 |
| JPH06501479A (ja) * | 1990-11-08 | 1994-02-17 | スタンフオード・ルツク・リミテツド | 抗原担体 |
| GB9211736D0 (en) * | 1992-06-03 | 1992-07-15 | Univ Cardiff | Allergic treatment |
| EP0941315B1 (en) * | 1996-11-26 | 2006-03-01 | Stressgen Biotechnologies Corporation | Fusion proteins containing stress proteins for inducing immune responses |
-
1999
- 1999-01-22 BR BR9907228-9A patent/BR9907228A/pt not_active IP Right Cessation
- 1999-01-22 IL IL13740499A patent/IL137404A0/xx unknown
- 1999-01-22 CA CA002318263A patent/CA2318263A1/en not_active Abandoned
- 1999-01-22 JP JP2000528300A patent/JP2002509074A/ja active Pending
- 1999-01-22 CN CN99804346A patent/CN1324243A/zh active Pending
- 1999-01-22 HU HU0100241A patent/HUP0100241A2/hu unknown
- 1999-01-22 EP EP99903321A patent/EP1049483A1/en not_active Withdrawn
- 1999-01-22 TR TR2000/02973T patent/TR200002973T2/xx unknown
- 1999-01-22 ZA ZA9900499A patent/ZA99499B/xx unknown
- 1999-01-22 WO PCT/US1999/001421 patent/WO1999037319A1/en not_active Ceased
- 1999-01-22 CZ CZ20002669A patent/CZ20002669A3/cs unknown
- 1999-01-22 KR KR1020007008033A patent/KR20010040389A/ko not_active Withdrawn
- 1999-01-22 PL PL99342166A patent/PL342166A1/xx not_active Application Discontinuation
- 1999-01-22 AU AU23374/99A patent/AU2337499A/en not_active Abandoned
-
2000
- 2000-07-21 NO NO20003775A patent/NO20003775L/no not_active Application Discontinuation
-
2001
- 2001-08-17 US US09/932,483 patent/US20020006410A1/en not_active Abandoned
-
2006
- 2006-09-25 US US11/534,782 patent/US20070179087A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002509074A5 (enExample) | ||
| CA2360248A1 (en) | Combinations of formoterol and a tiotropium salt | |
| NZ513526A (en) | Combinations of formoterol and fluticasone propionate for asthma | |
| JP2004538303A5 (enExample) | ||
| ES2178943A1 (es) | Uso de compuestos organicos en el tratamiento de enfermedad pulmonar obstructiva cronica. | |
| JP2001520985A5 (enExample) | ||
| JP2005515966A5 (enExample) | ||
| RU2264401C3 (ru) | Производные хинуклидина, способ их получения, фармацевтическая композиция, способ лечения и промежуточные вещества | |
| JP2002522485A5 (enExample) | ||
| JP2006522006A5 (enExample) | ||
| EP1498411A4 (en) | DICETOHYDRAZINE DERIVATIVE COMPOUNDS AND MEDICAMENTS CONTAINING THESE COMPOUNDS AS ACTIVE INGREDIENTS | |
| CA2733294A1 (en) | Pharmaceutical combination of a tiotropium salt and ciclesonide | |
| JP2001503780A5 (enExample) | ||
| JP2003515569A5 (enExample) | ||
| WO2005011614A8 (en) | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-ige antibody for treatment of asthma or chronic obstructive pulmonary disease | |
| JP2002506864A5 (enExample) | ||
| JP2005513014A5 (enExample) | ||
| JP2003534281A5 (enExample) | ||
| JP2007504268A5 (enExample) | ||
| JP2002530353A5 (enExample) | ||
| JP2002509154A5 (enExample) | ||
| JP2003534282A5 (enExample) | ||
| WO2005011604A3 (en) | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease | |
| RU2004112422A (ru) | Роувастатин в преддеменционных состояниях | |
| JPH09315972A5 (enExample) |